Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M124Revenue (TTM) $M33.8Net Margin (%)-97.5Altman Z-Score-45.9
Enterprise Value $M27.1EPS (TTM) $-1.2Operating Margin %-93.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-98.6Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %-55.9Quick Ratio2.2Cash flow > EarningsN
Price/Sales1.95-y EBITDA Growth Rate %-29.2Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-49.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-182.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M43.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CTIC is held by these investors:



CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOVE RICHARD LDirector 2017-09-29Sell14,600$3.21-9.66view
BIANCO JAMES APresident and CEO 2016-06-24Sell1,000$3.7-21.62view
BIANCO JAMES APresident and CEO 2016-05-27Sell1,000$4.5-35.56view
BIANCO JAMES APresident and CEO 2016-04-29Sell1,000$5.2-44.23view
BIANCO JAMES APresident and CEO 2016-03-28Sell1,000$4.9-40.82view
BIANCO JAMES APresident and CEO 2016-03-21Sell31,817$5.5-47.27view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell1,000$5.9-50.85view
BIANCO JAMES APresident and CEO 2016-02-26Sell1,000$6.3-53.97view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell1,500$6.3-53.97view
BIANCO JAMES APresident and CEO 2016-02-16Sell10,000$4.2-30.95view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
CTI BioPharma to Present at the Jefferies 2017 London Healthcare Conference Nov 08 2017 
CTI BioPharma Reports Third Quarter 2017 Financial Results Nov 06 2017 
CTI BioPharma to Report Third Quarter 2017 Financial Results on November 6, 2017 Oct 30 2017 
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promoti Sep 26 2017 
CTI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference Aug 31 2017 
CTI BioPharma Reports Second Quarter 2017 Financial Results Aug 03 2017 
CTI BioPharma Announces Completion of Enrollment in the Phase 3 PIX306 Trial of PIXUVRI® for Aggres Aug 02 2017 
CTI BioPharma Announces First Patient Enrolled in Phase 2 Trial of Pacritinib in Patients with Myelo Aug 01 2017 
CTI BioPharma to Report Second Quarter 2017 Financial Results on August 3, 2017 Jul 27 2017 
CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors Jul 24 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK